UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cytokines in Graft-versus-Host Disease

The Journal of immunology (1950), 2015-05, Vol.194 (10), p.4604-4612

2015

Volltextzugriff (PDF)

MHC Class II Antigen Presentation by the Intestinal Epithelium Initiates Graft-versus-Host Disease and Is Influenced by the Microbiota

Immunity (Cambridge, Mass.), 2019-11, Vol.51 (5), p.885-898.e7

2019

Volltextzugriff (PDF)

Infectious complications of CAR T-cell therapy: a clinical update

Therapeutic Advances in Infectious Disease, 2021, Vol.8

2021

Volltextzugriff (PDF)

A phase 3 double-blind study of the addition of tocilizumab vs placebo to cyclosporin/methotrexate GVHD prophylaxis

Blood, 2021-04, Vol.137 (14), p.1970-1979

2021

Volltextzugriff (PDF)

IL-6 dysregulation originates in dendritic cells and mediates graft-versus-host disease via classical signaling

Blood, 2019-12, Vol.134 (23), p.2092-2106

2019

Volltextzugriff (PDF)

Acute graft-versus-host disease is regulated by an IL-17–sensitive microbiome

Blood, 2017-04, Vol.129 (15), p.2172-2185

2017

Volltextzugriff (PDF)

Donor T-cell–derived GM-CSF drives alloantigen presentation by dendritic cells in the gastrointestinal tract

Blood advances, 2019-10, Vol.3 (19), p.2859-2865

2019

Volltextzugriff (PDF)

Pegylated interferon-2α invokes graft-versus-leukemia effects in patients relapsing after allogeneic stem cell transplantation

Blood advances, 2019-10, Vol.3 (20), p.3013-3019

2019

Volltextzugriff (PDF)

Low rates of complications and β-lactam resistance in viridans group streptococci bloodstream infection among cancer patients receiving chemotherapy

Journal of antimicrobial chemotherapy, 2024-08, Vol.79 (8), p.2040-2047

2024

Volltextzugriff (PDF)

Recipient mucosal-associated invariant T cells control GVHD within the colon

The Journal of clinical investigation, 2018-05, Vol.128 (5), p.1919-1936

2018

Volltextzugriff (PDF)

IFN-λ therapy prevents severe gastrointestinal graft-versus-host disease

Blood, 2021-08, Vol.138 (8), p.722-737

2021

Volltextzugriff (PDF)

IFN-λ therapy prevents severe gastrointestinal graft-versus-host disease

Blood, 2021-08, Vol.138 (8), p.722-737

2021

Volltextzugriff (PDF)

CMV exposure drives long-term CD57+ CD4 memory T-cell inflation following allogeneic stem cell transplant

Blood, 2021-12, Vol.138 (26), p.2874-2885

2021

Volltextzugriff (PDF)

Clinical grade multiparametric cell sorting and gene-marking of regulatory T cells

Cytotherapy (Oxford, England), 2024-07, Vol.26 (7), p.719-728

2024

Volltextzugriff (PDF)

IL-6-mediated endothelial injury impairs antiviral humoral immunity after bone marrow transplantation

The Journal of clinical investigation, 2024-04, Vol.134 (7), p.1-14

2024

Volltextzugriff (PDF)

Flt-3L Expansion of Recipient CD8α + Dendritic Cells Deletes Alloreactive Donor T Cells and Represents an Alternative to Posttransplant Cyclophosphamide for the Prevention of GVHD

Clinical cancer research, 2018-04, Vol.24 (7), p.1604-1616

2018

Volltextzugriff (PDF)

Real-World Outcomes with CD19 CAR T-Cell Therapy for B-Cell Malignancies in Regional/Rural Australia: Results from the Queensland CAR T-Cell Program

Blood, 2022-11, Vol.140 (Supplement 1), p.7500-7501

2022

Volltextzugriff (PDF)

Early Cytomegalovirus Reactivation after Allogenic Bone Marrow Transplantation Is Associated with the Loss of Recipient-Derived Humoral Immunity and Is Reduced By IL-6 Inhibition

Blood, 2021-11, Vol.138 (Supplement 1), p.648-648

2021

Volltextzugriff (PDF)

Immune responses to the microbiome tune MHC class II antigen presentation by the intestinal epithelium to control gut pathology

The Journal of immunology (1950), 2019-05, Vol.202 (1_Supplement), p.69-69.38

2019

Volltextzugriff (PDF)

Acute graft-versus-host disease is regulated by an IL-17-sensitive microbiome

The Journal of immunology (1950), 2017-05, Vol.198 (1_Supplement), p.82-82.8

2017

Volltextzugriff (PDF)

Recipient CD8+ DC Delete Alloreactive Donor CTL and Promote Leukemic Relapse after Allogeneic BMT

Blood, 2015-12, Vol.126 (23), p.4279-4279

2015

Volltextzugriff (PDF)

Erratum: Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells

Nature medicine, 2018-04, Vol.24 (4), p.526-526

2018

Volltextzugriff (PDF)

Interferon Lambda Protects Gastrointestinal Stem Cells from Acute Gvhd

Transplantation and cellular therapy, 2021-03, Vol.27 (3), p.S78

2021

Volltextzugriff (PDF)

Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells

Nature medicine, 2018-03, Vol.24 (3), p.282-291

2018

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(38)

Sprache

Englisch
(38)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cytokines in Graft-versus-Host Disease

MHC Class II Antigen Presentation by the Intestinal Epithelium Initiates Graft-versus-Host Disease and Is Influenced by the Microbiota

Infectious complications of CAR T-cell therapy: a clinical update

A phase 3 double-blind study of the addition of tocilizumab vs placebo to cyclosporin/methotrexate GVHD prophylaxis

IL-6 dysregulation originates in dendritic cells and mediates graft-versus-host disease via classical signaling

Acute graft-versus-host disease is regulated by an IL-17–sensitive microbiome

Donor T-cell–derived GM-CSF drives alloantigen presentation by dendritic cells in the gastrointestinal tract

Pegylated interferon-2α invokes graft-versus-leukemia effects in patients relapsing after allogeneic stem cell transplantation

Low rates of complications and β-lactam resistance in viridans group streptococci bloodstream infection among cancer patients receiving chemotherapy

Recipient mucosal-associated invariant T cells control GVHD within the colon

IFN-λ therapy prevents severe gastrointestinal graft-versus-host disease

IFN-λ therapy prevents severe gastrointestinal graft-versus-host disease

CMV exposure drives long-term CD57+ CD4 memory T-cell inflation following allogeneic stem cell transplant

Clinical grade multiparametric cell sorting and gene-marking of regulatory T cells

IL-6-mediated endothelial injury impairs antiviral humoral immunity after bone marrow transplantation

Flt-3L Expansion of Recipient CD8α + Dendritic Cells Deletes Alloreactive Donor T Cells and Represents an Alternative to Posttransplant Cyclophosphamide for the Prevention of GVHD

Real-World Outcomes with CD19 CAR T-Cell Therapy for B-Cell Malignancies in Regional/Rural Australia: Results from the Queensland CAR T-Cell Program

Early Cytomegalovirus Reactivation after Allogenic Bone Marrow Transplantation Is Associated with the Loss of Recipient-Derived Humoral Immunity and Is Reduced By IL-6 Inhibition

Immune responses to the microbiome tune MHC class II antigen presentation by the intestinal epithelium to control gut pathology

In Vivo Expansion of Recipient DC Leads to Deletion of Donor Alloreactive CD8+ T Cells and Is an Alternative to Post-Transplant Cyclophosphamide for the Prevention of Graft-Versus-Host Disease after BMT

Acute graft-versus-host disease is regulated by an IL-17-sensitive microbiome

Recipient CD8+ DC Delete Alloreactive Donor CTL and Promote Leukemic Relapse after Allogeneic BMT

Erratum: Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells

Interferon Lambda Protects Gastrointestinal Stem Cells from Acute Gvhd

Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells

Suchergebnisse filtern